HealthStream Inc (HSTM)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $855.77M
Last updated: Nov 17, 2026 at 4:20 PM ET
HealthStream Inc (HSTM) Statistics
HealthStream (HSTM) has a market cap of $855.77M and an enterprise value of $796.80M. Its trailing P/E of 35.0x is below its 10-year median of 62.4x.
Total Valuation
Enterprise value is 6.89% below the market cap, as cash exceeds debt.
| Market Cap | $855.77M |
|---|---|
| Enterprise Value | $796.80M |
| Latest price (Nov 17, 2026) | $27.68 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 16, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 2, 2026 |
| Last Ex-Dividend Date | Nov 16, 2026 |
| Next Payment Date | Nov 27, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.5x and 2.0x. Its year-end P/E ranged from 33.0x to 131.8x from 2016 to 2025.
| P/E Ratio | 35.0x |
|---|---|
| Forward P/E | 36.7x |
| P/S Ratio | 2.5x |
| Forward P/S | 2.6x |
| P/B Ratio | 2.0x |
| P/TBV Ratio | 9.5x |
| P/FCF Ratio | 19.8x |
| P/OCF Ratio | 12.0x |
| PEG Ratio | 3.2 |
Enterprise Valuation
Counting debt and cash, the company is valued at 9.1x EBITDA and 18.4x free cash flow.
| EV / Earnings | 38.9x |
|---|---|
| EV / Sales | 2.4x |
| EV / EBITDA | 9.1x |
| EV / FCF | 18.4x |
Price Statistics
The stock is up 12.98% over 52 weeks and trades 10.80% below its 50-day average.
| Beta (1Y) | 0.40 |
|---|---|
| 52-Week Change | +12.98% |
| 1-Month Change | -16.34% |
| 3-Month Change | -2.79% |
| 6-Month Change | +16.64% |
| 5-Year Change | +26.64% |
| 10-Year Change | +24.95% |
| Total Return (1Y) | +13.67% |
| Total Return (3Y CAGR) | +3.33% |
| Total Return (5Y CAGR) | +2.12% |
| Return vs SPY (1Y) | +2.53% |
| Max Drawdown (1Y) | -22.55% |
| Max Drawdown (3Y) | -41.70% |
| Sharpe Ratio (1Y) | 0.39 |
| Correlation with SPY (1Y) | 0.16 |
| 50-Day Average | $31.03 |
| 200-Day Average | $25.97 |
| 52-Week Range | $19.39 to $35.57 |
| RSI (14 Days) | 29.3 |
| Average Volume (20 Days) | 249.74K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.48x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.48x |
|---|---|
| Quick Ratio | 1.48x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 5.10% over the last 12 months, against a 5-year average of 4.11%.
| Return on Equity (ROE) | 5.10% |
|---|---|
| Return on Assets (ROA) | 3.62% |
| ROE (5Y Average) | 4.11% |
| ROA (5Y Average) | 2.82% |
| ROIC (5Y Average) | 4.44% |
| Asset Turnover | 0.62x |
| Receivables Turnover | 8.68x |
Taxes
Income tax took 22.50% of pretax income over the last 12 months.
| Income Tax (TTM) | $5.95M |
|---|---|
| Effective Tax Rate | 22.50% |
Scores
HSTM has an Altman Z-Score of 4.18, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.18 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $327.95M over the last 12 months is up 9.83% from the 12 months before.
| Revenue | $327.95M |
|---|---|
| Revenue Growth (YoY) | +9.83% |
| Gross Profit | $212.32M |
| Operating Income | $24.82M |
| Pretax Income | $26.44M |
| Net Income | $20.49M |
| EBITDA | $83.21M |
| Reported EPS (TTM) | $0.79 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 71.03% of the $565.85M in total assets.
| Cash and Equivalents | $58.96M |
|---|---|
| Total Debt | $0 |
| Net Cash | $58.96M |
| Net Cash Per Share | $2.00 |
| Working Capital | $58.17M |
| Shareholder Equity | $401.94M |
| Book Value Per Share | $13.63 |
| Tangible Book Value | $85.80M |
| Tangible Book Per Share | $2.91 |
| Total Assets | $565.85M |
| Total Liabilities | $163.91M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $29.90M of capital spending, operating cash flow left $41.25M of free cash flow.
| Operating Cash Flow | $71.15M |
|---|---|
| Capital Expenditures | $29.90M |
| Free Cash Flow | $41.25M |
| FCF Per Share | $1.35 |
| Depreciation and Amortization | $58.84M |
| Dividends Paid | $3.99M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 7.57%, against a 5-year average of 5.50%.
| Gross Margin | 64.74% |
|---|---|
| Operating Margin | 7.57% |
| Pretax Margin | 8.06% |
| Net Margin | 6.25% |
| EBITDA Margin | 25.37% |
| FCF Margin | 12.58% |
| Gross Margin (5Y Average) | 65.50% |
| Operating Margin (5Y Average) | 5.50% |
| Net Margin (5Y Average) | 5.03% |
Growth
Revenue grew 4.45% a year over 3 years, and EPS 32.64% a year.
| Revenue Growth (3Y CAGR) | +4.45% |
|---|---|
| Revenue Growth (5Y CAGR) | +4.43% |
| EPS Growth (3Y CAGR) | +32.64% |
| EPS Growth (5Y CAGR) | +16.23% |
| FCF Growth (3Y CAGR) | +6.10% |
| FCF Growth (5Y CAGR) | +12.79% |
| Operating Income Growth (3Y CAGR) | +17.58% |
| Book Value Per Share Growth (2Y CAGR) | +3.23% |
| Tangible Book Per Share Growth (2Y CAGR) | -19.06% |
Dividends and Yields
HSTM pays out 7.09% of earnings as dividends.
| Dividend Per Share (Annual) | $0.14 |
|---|---|
| Dividend Yield | 0.51% |
| Payment Schedule | Quarterly |
| Payout Ratio | 7.09% |
| FCF Payout Ratio | 9.68% |
| Earnings Yield | 2.86% |
| FCF Yield | 5.05% |
| Buyback Yield | 1.75% |
| Shareholder Yield | 2.24% |
Peer Position
Against 7 similar companies, HSTM has the 3rd highest P/E.
P/E RatioPeer median 16.9x
P/S RatioPeer median 1.5x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.49%
Dividend YieldPeer median 0.00%
| P/E Ratio | 35.0x vs 16.9x median |
|---|---|
| P/S Ratio | 2.5x vs 1.5x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +9.83% vs +13.49% median |
| Dividend Yield | 0.51% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.76% and EPS growth at 14.64% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.76% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +14.64% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About HSTM
What is HSTM's market cap?
HealthStream has a market cap of $855.77M. Its enterprise value, which adds debt and subtracts cash, is $796.80M.
What is HSTM's P/E ratio?
HealthStream has a trailing P/E ratio of 35.0x and a forward P/E of 36.7x.
How many shares of HSTM are outstanding?
HealthStream has 29.49M shares outstanding. The count is down 0.66% from a year earlier.
Does HSTM pay a dividend?
Yes. HealthStream pays $0.14 a share a year, a dividend yield of 0.51%.
How much debt does HSTM have?
HealthStream has $0 of total debt and $58.96M of cash and equivalents, a net cash position of $58.96M.
HSTM pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts